PL1634602T3 - Zastosowanie roślin z rodzaju gojnika (Sideritis) do zapobiegania i wpływania na zaburzenia związane ze zmienioną serotoninergiczną neurotransmisją - Google Patents
Zastosowanie roślin z rodzaju gojnika (Sideritis) do zapobiegania i wpływania na zaburzenia związane ze zmienioną serotoninergiczną neurotransmisjąInfo
- Publication number
- PL1634602T3 PL1634602T3 PL05014057T PL05014057T PL1634602T3 PL 1634602 T3 PL1634602 T3 PL 1634602T3 PL 05014057 T PL05014057 T PL 05014057T PL 05014057 T PL05014057 T PL 05014057T PL 1634602 T3 PL1634602 T3 PL 1634602T3
- Authority
- PL
- Poland
- Prior art keywords
- plants
- disturbances
- correlated
- preventing
- changed
- Prior art date
Links
- 241000196324 Embryophyta Species 0.000 title abstract 3
- 230000002295 serotoninergic effect Effects 0.000 title abstract 3
- 230000005062 synaptic transmission Effects 0.000 title abstract 3
- 235000012864 Sideritis Nutrition 0.000 title abstract 2
- 241000011901 Sideritis Species 0.000 title abstract 2
- 230000002596 correlated effect Effects 0.000 title 1
- 208000030814 Eating disease Diseases 0.000 abstract 2
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 2
- 208000032841 Bulimia Diseases 0.000 abstract 1
- 206010006550 Bulimia nervosa Diseases 0.000 abstract 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010010219 Compulsions Diseases 0.000 abstract 1
- 206010027304 Menopausal symptoms Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010033664 Panic attack Diseases 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 238000000099 in vitro assay Methods 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Botany (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydroponics (AREA)
- Compounds Of Unknown Constitution (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004032165A DE102004032165A1 (de) | 2004-07-02 | 2004-07-02 | Verwendung von Pflanzen der Gattung Sideritis zur Vorbeugung und Beeinflussung von Störungen, die mit einer veränderten serotoninergen Neurotransmission verbunden sind |
| EP05014057A EP1634602B1 (de) | 2004-07-02 | 2005-06-29 | Verwendung von Pflanzen der Gattung Sideritis zur Vorbeugung und Beeinflussung von Störungen, die mit einer veränderten serotoninergen Neurotransmission verbunden sind |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1634602T3 true PL1634602T3 (pl) | 2011-05-31 |
Family
ID=34978868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05014057T PL1634602T3 (pl) | 2004-07-02 | 2005-06-29 | Zastosowanie roślin z rodzaju gojnika (Sideritis) do zapobiegania i wpływania na zaburzenia związane ze zmienioną serotoninergiczną neurotransmisją |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1634602B1 (pl) |
| AT (1) | ATE481975T1 (pl) |
| DE (2) | DE102004032165A1 (pl) |
| ES (1) | ES2353506T3 (pl) |
| PL (1) | PL1634602T3 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2515922E (pt) | 2009-12-23 | 2013-10-31 | Finzelberg Gmbh & Co Kg | Extractos vegetais para o tratamento de doenças neurodegenerativas |
| PT2608798E (pt) | 2010-08-27 | 2015-03-26 | Finzelberg Gmbh & Co Kg | Extractos vegetais de sideritis e sua utilização para aumentar o desempenho cognitivo |
| EP3708177A3 (en) | 2013-07-09 | 2021-01-13 | Georgios Pandalis | Reuptake inhibitors |
| DE102015014473A1 (de) | 2015-11-09 | 2017-05-11 | Dr. Loges + Co. Gmbh | Kombination von Bacopa monnieri und Sideritis ssp. zur Prophylaxe von Unruhezuständen und Schlafstörungen |
-
2004
- 2004-07-02 DE DE102004032165A patent/DE102004032165A1/de not_active Withdrawn
-
2005
- 2005-06-29 EP EP05014057A patent/EP1634602B1/de not_active Expired - Lifetime
- 2005-06-29 DE DE502005010283T patent/DE502005010283D1/de not_active Expired - Lifetime
- 2005-06-29 ES ES05014057T patent/ES2353506T3/es not_active Expired - Lifetime
- 2005-06-29 AT AT05014057T patent/ATE481975T1/de active
- 2005-06-29 PL PL05014057T patent/PL1634602T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2353506T3 (es) | 2011-03-02 |
| DE502005010283D1 (de) | 2010-11-04 |
| ATE481975T1 (de) | 2010-10-15 |
| DE102004032165A1 (de) | 2006-02-09 |
| EP1634602A3 (de) | 2008-07-09 |
| EP1634602A2 (de) | 2006-03-15 |
| EP1634602B1 (de) | 2010-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006096434A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders | |
| HK1047692A1 (zh) | 治疗全身性焦虑障碍的环苯扎林及其组合物 | |
| WO2008089008A3 (en) | Tetrahydrobiopterin prodrugs | |
| MXPA04005790A (es) | Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona. | |
| WO2007089851A3 (en) | Compositions and methods for treating collagen-mediated diseases | |
| WO2006047516A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| WO2007127803A3 (en) | Administration of growth factors for the treatment of cns disorders | |
| WO2005102335A3 (en) | Methods of treating sleep disorders | |
| WO2008011363A3 (en) | Quercetin-containing compositions | |
| WO2008076754A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| WO2005063232A8 (en) | Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity | |
| WO2007016155A3 (en) | Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders | |
| TW200621765A (en) | Substituted phenylaminothiazoles and their use | |
| WO2007009120A3 (en) | Heterotetracyclic compounds as tpo mimetics | |
| WO2005086656A3 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
| PT1778680E (pt) | Derivados espirocíclicos de ciclo-hexano | |
| WO2002026244A3 (en) | Compositions and methods of use for extracts of rutaceae plants | |
| WO2007136741A3 (en) | N-desmethyl-doxepin and methods of using the same to treat sleep disorders | |
| GB0420831D0 (en) | Novel compounds | |
| MY143278A (en) | Treatment of neurotic disorders. | |
| IL190831A0 (en) | Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion | |
| EP1935418A4 (en) | Composition for relieving subjective symptoms of fatigue | |
| NZ591136A (en) | A composition for treating aids and associated conditions comprising plant extracts | |
| WO2007022269A3 (en) | Compounds and compositions as tpo mimetics | |
| PL1634602T3 (pl) | Zastosowanie roślin z rodzaju gojnika (Sideritis) do zapobiegania i wpływania na zaburzenia związane ze zmienioną serotoninergiczną neurotransmisją |